Emergent Biosolutions (EBS) Q2 2024 Earnings Report

1,362 Followers

EBS Q2 2024 EPS Results

Actual EPS-$2.32

Consensus EPS-$1.14

Beat/MissMissed by -$1.18

One Year Ago EPS-$1.06

Actual Revenue$254.70M

Expected Revenue$190.00M

Beat/MissBeat by +$64.70M

YoY Revenue Growth-24.62%

QuarterQ2 2024

Date08/06/2024

TimeAfter Close

Conference CallTuesday, August 6, 2024

EBS Upcoming Earnings

Emergent Biosolutions's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

EBS Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-0.39 / -	1.06	―
Aug 05, 2026	2026 (Q2)	-0.09 / 0.60	0.16	275.00% (+0.44)
Apr 30, 2026	2026 (Q1)	-0.25 / 0.21	0.71	-70.42% (-0.50)
Feb 26, 2026	2025 (Q4)	0.11 / -0.43	0.05	-960.00% (-0.48)
Oct 29, 2025	2025 (Q3)	-0.12 / 1.06	1.37	-22.63% (-0.31)
Aug 06, 2025	2025 (Q2)	-0.49 / 0.16	-2.32	106.90% (+2.48)
May 07, 2025	2025 (Q1)	0.44 / 0.71	0.59	20.34% (+0.12)
Mar 03, 2025	2024 (Q4)	-0.50 / 0.05	-0.77	106.49% (+0.82)
Nov 06, 2024	2024 (Q3)	0.10 / 1.37	-0.54	353.70% (+1.91)
Aug 06, 2024	2024 (Q2)	-1.14 / -2.32	-1.06	-118.87% (-1.26)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed